Latest News and Blog


Subscribe to The CME Pulse today to receive timely updates from Global Education Group on the latest trends, regulatory updates, and hot topics in the CME enterprise, delivered straight to your inbox! 

Global to attend CBI’s 17th Annual Independent Medical Education and Grants Summit

September 16th-17th, 2019 in Philadelphia, PA

By John McCormick - September 11, 2019

Global will be attending CBI’s 17th Annual Independent Medical Education and Grants Summit, September 16th-17th, 2019 in Philadelphia, PA. The conference convenes commercial supporters, providers (MECCs, Medical Specialty Societies and Academic Medical Institutions) and other key healthcare stakeholders to address leading industry issues centered around improving and standardizing outcomes/assessment methodologies, understanding learner needs, linking CME to patient/healthcare impact and demonstrating the value of CME. This year’s program assembles an impressive faculty of 30+ industry leaders to share perspectives and engage in a robust dialogue examining new innovations, tools and future trends in high-quality medical education.

John McCormick, Global's Director of Education Strategy & Analytics, will be attending the conference. If you would like to schedule a meeting to learn more about Global's CME joint providership services, please contact John directly via email, or by phone at 303-395-1782 X 75.

We are excited to see everyone in Philadelphia and look forward to an informative and engaging meeting.
Read More...

2019 Grant Approval and Profitability Scale

Request the updated report today!

By John McCormick - September 11, 2019

With a managed network of clinicians, scientists and specialists, Global collects advanced intelligence on CME funding sources and opportunities from both commercial and non-commercial sources. 

The Grant Approval and Profitability Scale was developed as a resource for our education partners, as there continues to be a growing need for developing high-quality CME in the face of decreasing commercial supporter budgets. The first version of the scale, developed in 2014, identified 37 successfully funded live and enduring CME activities, and analyzed the top 10-12 budget line items for high, low, and average costs.

Global released an updated version of the scale in 2016 and decided to dig a little deeper into the data. The 2016 Grant Approval and Profitability Scale analyzed a broader range of program format types and budget line items. Global also calculated the total cost per learner at grant funded CME activities as well as the management fees as a percentage of the total program budget.

The 2017-2018 scale expands on our work from previous years, with updates to programs and format types. The report covers grant funded activities that launched and concluded over a two year span, from January 2017 and December 2018.

Please follow this link to request your copy of the 2019 Grant Approval and Profitability Scale. If you have any questions please contact us at inquire@globaleducationgroup.com.
Read More...

How much do you know about the science of cannabis?


By John McCormick - August 29, 2019

Medical marijuana is legal in some form in 33 states and the District of Columbia, and more are considering bills to do the same. Overall, marijuana use and acceptance is increasing rapidly, yet many healthcare providers and community members do not recognize the basic science of the endocannabinoid system. Marijuana is being marketed as a treatment for certain psychiatric conditions including PTSD, depression, and anxiety. However, there is a dearth of literature supporting the use of marijuana in psychiatry and practitioners are likely unaware of the negative consequences associated with marijuana use.

Additionally, the regulation of marijuana and its use in therapy, is complex and unique: cultivation and distribution of this substance, regardless of purpose, remain illegal at the federal level. Many healthcare providers are unaware of new regulations and guidelines. The marijuana landscape is changing rapidly – CMP is here to help catch you up on all the changes!  Register now – space is limited!

Test your knowledge with this quick quiz about the science of cannabis! 

 
Read More...

2018 ACCME Annual Report


By John McCormick - August 20, 2019

2018 ACCME Annual Report and Analysis
The 2018 ACCME Annual Report data, released July 17th, 2019,  shows the following for CME activities respective to the 2017 report;
  • 61% growth in non-physician participants
  • 1% decline in physician participants
  • 5% increase in total CME income, including registration fees, monetary support, advertising/exhibits, donations, and grants
The three-year trend data shows that since 2016, the number of physician participants at CME activities has slightly increased by 2%, while the number of non-physician participants increased by 71%. The significant increase in non-physician attendees at CME activities is largely due to more comprehensive data collection from jointly accredited providers, as described by the ACCME below:

New This Year: More Comprehensive Data about Interprofessional Continuing Education

In support of our strategic goal to advance data systems, the three founding members of Joint Accreditation for Interprofessional Continuing Education—the ACCME, Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC)— launched the Joint Accreditation Program and Activity Reporting System (JA-PARS), enabling jointly accredited providers to report all of their program and activity data, including uni-professional and interprofessional continuing education (IPCE) activities, into a single, unified repository. Before 2018, jointly accredited providers reported data into multiple accreditors’ data systems. We can now see a more comprehensive picture of the scope of IPCE.

2018 Highlights
  • Non-physician interactions at CME activities increased from approximately 12 million in 2017, to over 20 million in 2018, respectively - a 61% increase in non-physician interactions
  • Total commercial support contributions rose from $740 million to $748 million, an increase of approximately 1% from 2017 numbers
  • Income from advertising and exhibits rose from $434 million in 2017 to nearly $500 million in 2018 - a 14% increase
  • Commercially supported activities averaged 150 physician learners per activity in 2018
    • Non-commercially supported activities averaged 81 physician learners per activity
  • Of the total attendance at CME activities
    • 43% (15,457,998) were physicians
    • 57% (20,708,037) were non-physicians
  • Publishing and / or Education companies secured approximately 59% ($443,398,259) of the total commercial support income earned by ACCME accredited providers in 2018
If you have any questions or would like to request a copy of the report, please feel free to contact us at inquire@globaleducationgroup.com
Read More...

Global to host cannabis and medical marijuana CME Conference in Denver, October 4, 2019


By John McCormick - July 26, 2019

Global Education Group is pleased to announce that we will be hosting a CME / CE conference on October 4, 2019, in Denver, CO. CMP 2019 focuses on the entire endocannabinoid system, medical cannabis, and marijuana.

Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP 2019) is an educational and accredited CME / CE live conference which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policy and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry.

CMP Symposium 2019 is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medical cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.

Overall, the participants of Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP 2019) will benefit from learning about recent and emerging clinical practices involving the endocannabinoid system.

Regardless of your role in the medical community, CMP Symposium 2019 is for you, and an excellent way to earn CME credits while learning about the emerging fields of medical marijuana, cannabis, and the endocannabinoid system.

Accreditation Information

This activity is provided by Global Education Group.

This activity is approved for 2 COPIC Points.

Target Audience

This educational activity is designed to meet the needs of primary care practitioners inclusive of: physicians, nurse practitioners, physician assistants, and pharmacists who have interest in the emerging field of cannabis.

Statement of Need/Program Overview
This symposium is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medicinal cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.

Learning Objectives
After completing this activity, participants should be able to:

  1. Outline the endocannabinoid system.
  2. Review the current evidence-based indications for the use of cannabis.
  3. Review the effects of cannabis use, including physiological effects.
  4. Describe the Colorado experience after mass commercialization of cannabis for medical purposes.
  5. Review Colorado Medical Board Rules, Regulations and Policies impact on cannabinoid use.
  6. Recognize FDA policy and regulation of CBD-containing products for therapeutic use.
  7. Explain the interaction of cannabis and opioids.
  8. Review the known risks for psychiatric complications related to cannabinoid use.
  9. Discuss recent studies of cannabinoids in the treatment of psychiatric disorders.
  10. Discuss what is known about cannabinoid exposure in developing brains.
  11. Identify major epidemiological trends associated with cannabis legalization.
  12. Describe common emergency department presentations related to cannabis use.
  13. Identify best practices for discussing cannabinoid use in Colorado’s legal and regulatory climate.
Faculty
• Alan M. Lembitz, MD - Chief Medical Officer - COPIC
• Brad Roberts, MD - Emergency Medicine Physician - Parkview Medical Center
• Deann Zenisek, JD - Attorney - Conklin Cardone & Rutberg, PC
• Doris Gundersen, MD - Medical Director - Colorado Physician Health Program
• Karen Randall, DO - Emergency Medicine Physician - Southern Colorado Emergency Medicine Associates
• Kenneth P. Finn, MD - President and Founder - Springs Rehabilitation, P.C.
• Leeann Blaskowski, NNP - Neonatal Nurse Practitioner - St. Francis Medical Center
• Lisa Robin - Chief Advocacy Officer - Federation of State Medical Boards
• Phillip Drum, PharmD - Pharmacy Consultant - Kaiser Permanente
• Shauna Callan, PhD - Co Founder and Director of Scientific Content - Headwaters Communications
• Stephen Ziegler, JD, PhD - Professor Emeritus of Public Policy - Purdue University

Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this live CME activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Global Education Group designates this continuing education activity for 7.5 contact hour(s) (0.75 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number 0530-0000-19-101-L04-P, 0530-0000-19-092-L01-P, 0530-0000-19-093-L03-P, 0530-0000-19-094-L03-P, 0530-0000-19-095-L03-P,
0530-0000-19-096-L04-P, 0530-0000-19-097-L04-P, 0530-0000-19-098-L04-P, 0530-0000-19-099-L04-P, 0530-0000-19-100-L04-P).

This is a knowledge-based activity

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Instructions to Receive Credit
In order to receive CME/CE and/or COPIC Points you must complete a post test/evaluation form after the event concludes. No credit will be given without a fully completed post evaluation form. A link to this will be emailed to your registered email address.

Fee & Refund/Cancellation Policy
There is a fee for this educational activity.

A refund will be issued for cancellations on or before 9/4/2019 less a $79 administration fee. No refunds will be permitted after 9/4/2019. Registrations may, however, be transferred to another individual or to a future meeting.

Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

• Alan M. Lembitz, MD – Nothing to disclose
• Brad Roberts, MD – Nothing to disclose
• Deann Zenisek, JD – Nothing to disclose
• Doris Gundersen, MD – Nothing to disclose
• Karen Randall, DO – Nothing to disclose
• Kenneth P. Finn, MD – Nothing to disclose
• Leeann Blaskowski, NNP – Nothing to disclose
• Lisa Robin – Nothing to disclose
• Phillip Drum, PharmD – Nothing to disclose
• Shauna Callan, PhD – Nothing to disclose
• Stephen Ziegler, JD, PhD – Nothing to disclose

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

• Andrea Funk – Nothing to disclose
• Ashley Cann – Nothing to disclose
• Carlos Ferreira – Nothing to disclose
• Esther Langmack, MD – Nothing to disclose
• Liddy Knight – Nothing to disclose
• Lindsay Borvansky, PT, DPT, ATC – Nothing to disclose
• Matthew Callan, PhD – Nothing to disclose

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

To learn more about the conference visit us online at www.cmpsymposium.com.
 
Read More...